138 related articles for article (PubMed ID: 33730624)
1. Recent advances in development of hetero-bivalent kinase inhibitors.
Lee S; Kim J; Jo J; Chang JW; Sim J; Yun H
Eur J Med Chem; 2021 Apr; 216():113318. PubMed ID: 33730624
[TBL] [Abstract][Full Text] [Related]
2. De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments.
Urich R; Wishart G; Kiczun M; Richters A; Tidten-Luksch N; Rauh D; Sherborne B; Wyatt PG; Brenk R
ACS Chem Biol; 2013 May; 8(5):1044-52. PubMed ID: 23534475
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into AGC kinase inhibition.
Breitenlechner C; Gassel M; Engh R; Bossemeyer D
Oncol Res; 2004; 14(6):267-78. PubMed ID: 15206489
[TBL] [Abstract][Full Text] [Related]
4. Bivalent inhibitors of the tyrosine kinases ABL and SRC: determinants of potency and selectivity.
Hill ZB; Perera BG; Maly DJ
Mol Biosyst; 2011 Feb; 7(2):447-56. PubMed ID: 21060940
[TBL] [Abstract][Full Text] [Related]
5. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
Johnson TK; Soellner MB
Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
[TBL] [Abstract][Full Text] [Related]
6. Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors.
Schoene J; Gazzi T; Lindemann P; Christmann M; Volkamer A; Nazaré M
ChemMedChem; 2019 Aug; 14(16):1514-1527. PubMed ID: 31264364
[TBL] [Abstract][Full Text] [Related]
7. 3,3',5-Triiodo-L-thyronine up-regulation of Na,K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent.
Lei J; Mariash CN; Ingbar DH
J Biol Chem; 2004 Nov; 279(46):47589-600. PubMed ID: 15342623
[TBL] [Abstract][Full Text] [Related]
8. Bivalent inhibitors of protein kinases.
Gower CM; Chang ME; Maly DJ
Crit Rev Biochem Mol Biol; 2014; 49(2):102-15. PubMed ID: 24564382
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in inhibitors of C-terminal SRC kinase.
P O'Malley D
Future Med Chem; 2020 Aug; 12(16):1447-1449. PubMed ID: 32638626
[No Abstract] [Full Text] [Related]
10. Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening.
Piala AT; Akella R; Potts MB; Dudics-Giagnocavo SA; He H; Wei S; White MA; Posner BA; Goldsmith EJ
Bioorg Med Chem Lett; 2016 Aug; 26(16):3923-7. PubMed ID: 27426302
[TBL] [Abstract][Full Text] [Related]
11. A historical overview of protein kinases and their targeted small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
[TBL] [Abstract][Full Text] [Related]
12. Selection of fragments for kinase inhibitor design: decoration is key.
Czodrowski P; Hölzemann G; Barnickel G; Greiner H; Musil D
J Med Chem; 2015 Jan; 58(1):457-65. PubMed ID: 25437144
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and characterization of "clickable" 4-anilinoquinazoline kinase inhibitors.
Perera BG; Maly DJ
Mol Biosyst; 2008 Jun; 4(6):542-50. PubMed ID: 18493651
[TBL] [Abstract][Full Text] [Related]
14. Towards the Development of Small-Molecule MO25 Binders as Potential Indirect SPAK/OSR1 Kinase Inhibitors.
Kadri H; Alamri MA; Navratilova IH; Alderwick LJ; Simpkins NS; Mehellou Y
Chembiochem; 2017 Mar; 18(5):460-465. PubMed ID: 28004876
[TBL] [Abstract][Full Text] [Related]
15. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
Chaudhary D; Robinson S; Romero DL
J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous inhibition assay for human and microbial kinases via MALDI-MS/MS.
Smith AM; Brennan JD
Chembiochem; 2014 Mar; 15(4):587-94. PubMed ID: 24478228
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Src family tyrosine kinase activity blocks glutamate signalling to ERK1/2 and Akt/PKB but not JNK in cultured striatal neurones.
Crossthwaite AJ; Valli H; Williams RJ
J Neurochem; 2004 Mar; 88(5):1127-39. PubMed ID: 15009668
[TBL] [Abstract][Full Text] [Related]
19. Recent developments of small molecule PI3K/mTOR dual inhibitors.
Liu YN; Wan RZ; Liu ZP
Mini Rev Med Chem; 2013 Dec; 13(14):2047-59. PubMed ID: 24195664
[TBL] [Abstract][Full Text] [Related]
20. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
